Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema

Respirology

Volumn 10, Issue 5, 2005, Pages 572-578

  Kurashima, Kazuyoshi ^a,b   Kanauchi, Tetsu ^a   Takayanagi, Noboru ^a   Sato, Nagato ^a   Tokunaga, Daido ^a   Ubukata, Mikio ^a   Yanagisawa, Tsutomu ^a   Sugita, Yutaka ^a   Kanazawa, Minoru ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Saitama Cardiovascular and Respiratory Center ^*  (Japan)

Author keywords

Chlamydia pneumoniae; Chronic obstructive pulmonary disease; Emphysema; Enzyme linked immunosorbent assay; High resolution computed tomography

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; EMPHYSEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; BLOOD; CHLAMYDIASIS; EPIDEMIOLOGY; HOSPITALIZATION; IMMUNOLOGY; JAPAN; LUNG EMPHYSEMA; MICROBIOLOGY; NONPARAMETRIC TEST; RADIOGRAPHY; RISK FACTOR;

AGED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; JAPAN; MALE; PULMONARY EMPHYSEMA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644837422     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00752.x     Document Type: Article

References (39)

1. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-6.
2. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 1992; 116: 273-8.
3. Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R. Chlamydia pneumoniae and asthma. Thorax 1998; 53: 254-9.
4. Marie TJ. Chlamydia pneumoniae. Thorax 1993; 48: 1-4.
5. Soler N, Torres A, Ewig S et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am. J. Respir. Crit. Care Med. 1998; 157: 1498-505.
6. Blasi F, Legnani D, Lombardo VW et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur. Respir. J. 1993; 6: 19-22.
7. von Hertzen L, Isoaho R, Leinonen M et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int. J. Epidemiol. 1996; 25: 658-64.
8. Dechend R, Maass M, Gieffers J et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa B and induces tissue factor and PAI-1 expression. Circulation 1999; 100: 1369-73.
9. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb. Pathog. 1996; 21: 215-21.
10. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol. 1995; 25: S9-12.
11. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydia heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98: 300-7.
12. Kim MP, Gaydos CA, Wood BJ, Hardick JP, Zhang Y, Wahl LM. Chlamydia pneumoniae enhances cytokinestimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism. Infect. Immun. 2005; 73: 632-4.
13. Finlay GA, O'Driscoll LR, Russell KJ et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am. J. Respir. Crit. Care Med. 1997; 156: 240-7.
14. Wu L, Skinner SJ, Lambie N, Vuletic JC, Blasi F, Black PN. Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 162: 1148-51.
15. Bergin C, Muller N, Nichols DM et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am. Rev. Respir. Dis. 1986; 133: 541-6.
16. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am. J. Respir. Crit. Care Med. 1995; 152: 653-7.
17. Gevenois PA, De Vuyst P, de Maertelaer V et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am. J. Respir. Crit. Care Med. 1996; 154: 187-92.
18. Kuwano K, Matsuba K, Ikeda T et al. The diagnosis of mild emphysema. Comparison of computed tomography and pathology scores. Am. Rev. Respir. Dis. 1990; 141: 169-78.
19. Sakai N, Mishima M, Nishimura K, Itoh H, Kuno K. An automated method to assess the distribution of low attenuation areas on chest CT scans in chronic pulmonary emphysema patients. Chest 1994; 106: 1319-25.
20. Coxson HO, Rogers RM, Whittall KP et al. A quantification of the lung surface area in emphysema using computed tomography. Am. J. Respir. Crit. Care Med. 1999; 159: 851-6.
21. Nakano Y, Sakai H, Muro S et al. Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax 1999; 54: 384-9.
22. Mishima M, Hirai T, Itoh H et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc. Natl Acad. Sci. USA 1999; 96: 8829-34.
23. Mishima M, Itoh H, Sakai H et al. Optimized scanning conditions of high resolution CT in the follow-up of pulmonary emphysema. J. Comput. Assist. Tomogr. 1999; 23: 380-4.
24. Gevenois PA, Scillia P, de Maertelaer V, Michils A, De Vuyst P, Yernault JC. The effects of age, sex, lung size, and hyperinflation on CT lung densitometry. Am. J. Roentgenol. 1996; 167: 1169-73.
25. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256-76.
26. Miniati M, Filippi E, Falaschi F et al. Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 151: 1359-67.
27. Numazaki K, Ikebe T, Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol. Med. Microbiol. 1996; 14: 179-83.
28. Kishimoto T, Kubota Y, Matsushima T et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method: 1. Evaluation of ELISA kit using outer membrane complex. Kansenshogaku Zasshi 1996; 70: 821-9 (in Japanese).
29. Kishimoto T, Kubota Y, Matsushima T et al. Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method: 2. Studies on clinical usefulness and serological diagnostic standard. Kansenshogaku Zasshi 1996; 70: 830-9 (in Japanese).
30. Wang SP, Grayston JT. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol. 1970; 70: 367-74.
31. Nakano Y, Muller NL, King GG et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002; 122 (Suppl. 6): 271S-5S.
32. Nakano Y, Muro S, Sakai H et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Am. J. Respir. Crit. Care Med. 2000; 162: 1102-8.
33. Blasi F, Damato S, Cosentini R et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002; 57: 672-6.
34. Shemer-Aveny Y, Lieberman D. Chlamydia pneumoniae-induced cilostasis in ciliated bronchial epithelial cells. J. Infect. Dis. 1995; 171: 1274-8.
35. Theegarten D, Mogilevski G, Anhenn O, Stamatis G, Jaeschock R, Morgenroth K. The role of Chlamydia in the pathogenesis of pulmonary emphysema. Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis. Virchows Arch. 2000; 437: 190-3.
36. Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Center for Disease Control (Canada). Clin. Infect. Dis. 2001; 33: 492-503.
37. Hahn DL. Chlamydia pneumonia, asthma, and COPD: what is the evidence? Ann. Allergy Asthma Immunol. 1999; 83: 271-92.
38. Aldous MB, Grayston JT, Wang SP, Foy HM. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J. Infect. Dis. 1992; 166: 646-9.
39. Hammerschlag MR, Chirgwin K, Roblin PM et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 1992; 14: 178-82.